Enhanced offers an online route to testosterone assessment and injectable treatment. Its presentation combines clinical review with confident messages about performance and recovery. For a reader considering continuing care, the practical issue is whether the offer clearly connects diagnosis, medicine, payment and access to the prescriber.
We checked the company's injection product page, dedicated TRT offer and service terms on October 13, 2026. We did not submit health information or place an order. These notes describe the public service and its unanswered questions, without a patient story or an independent claim about treatment results.
- Confirm how the entry charge relates to the selected supply plan.
- The published cypionate offer is described as compounded.
- Clinical follow-up and state eligibility need their own answers.
Clarify what happens after getting started
The main injection page shows a $49 get-started amount and describes labs, a clinician consultation, medicine and follow-up. It does not clearly price every future month of that entire service at $49. Ask what that first charge covers and when another payment would be required if the clinician considers treatment appropriate.
The pricing checklist helps distinguish an assessment fee from recurring care or a prepaid supply. Record the amount due today and the next expected charge. We have not entered checkout to determine which offer applies to a specific person, and a low opening amount cannot establish an annual treatment cost.
Read the separate supply commitments
Enhanced's dedicated TRT page lists monthly equivalents of $199 for one month, $179 for three months and $169 for six months. Confirm whether the longer selections are paid upfront and how they renew. Ask how a prescription adjustment or decision to stop affects medication and clinical services already paid for.
The offer says a reader who is found medically ineligible can receive a refund. That statement is narrower than a promise that all payments can be canceled or returned after prescribing. Request the terms attached to the selected transaction rather than borrowing a refund assumption from an entry offer or a different Enhanced product.
Keep the finished preparation identifiable
The dedicated offer explicitly names testosterone cypionate and describes compounded medicines supplied through licensed pharmacies. Obtain the actual pharmacy, concentration, ingredients and dispensing instructions for the proposed order. We have not independently verified every pharmacy claim or examined the supplied preparation.
FDA states that compounded medicines are not FDA-approved and are not assessed before marketing through its usual approval process. Our compounded-testosterone questions help separate the ingredient from the finished product. Ask why compounding is proposed and what alternatives have been considered; personalization alone does not demonstrate superior effectiveness or safety.
Let evaluation determine the next step
Enhanced describes clinician review of bloodwork and medical history before prescribing, followed by a twelve-week adjustment period. These are descriptions of its intended care process. They do not establish that every reader has testosterone deficiency or will experience the advertised improvements in energy, strength or recovery.
Endocrine Society guidance calls for symptoms and consistently low testosterone confirmed by repeat morning testing, with investigation of the underlying cause. Ask what would lead the clinician away from TRT. The first-appointment article helps prepare that discussion without using a performance target as a substitute for a diagnosis.
Know who responds to a result or concern
The injection page lists monitored markers including hematocrit and PSA alongside testosterone and other measures. Ask who reviews each result, how findings are communicated and how an abnormal result changes care. A laboratory list does not establish a response pathway or prove that every later test is included in the price.
Discuss blood pressure and fertility goals before accepting a prescription. FDA now requires increased-blood-pressure warnings for testosterone products, and endocrine guidance advises against starting testosterone when near-term fertility is planned. Our CBC discussion and follow-up guide supply questions for the professional conversation, not instructions for adjusting treatment.
Check the practical limits of remote care
Confirm availability in the state where you will receive the service and how travel or moving affects it. Enhanced separately advertises coaching with state limitations. Ask whether coaching is included and who retains clinical responsibility; additional support should not make the prescribing contact harder to identify.
For an office-based contrast, read Lowcountry Male. Enhanced's clearly named injectable offer may be worth investigating, but the relationship between its starting charge, supply options and continuing follow-up still needs a written explanation. A sustainable arrangement is one you can understand at renewal as well as at the first payment.
Sources & reading notes
Provider pages describe advertised services, not independently verified outcomes. Prices and eligibility may change. Research checked October 13, 2026. Article updated October 13, 2026.
- Enhanced: testosterone injections and get-started offer (checked October 13, 2026)
- Enhanced: TRT supply offers and compounded cypionate (checked October 13, 2026)
- Enhanced: terms of service (checked October 13, 2026)
- Endocrine Society: testosterone therapy guideline (checked October 13, 2026)
- FDA: class-wide testosterone labeling changes (checked October 13, 2026)
- FDA: risks of compounded medicines (checked October 13, 2026)